학술논문
Pembrolizumab vs placebo for early-stage non‒small-cell lung cancer after resection and adjuvant therapy: Subgroup analysis of patients who received adjuvant chemotherapy in the phase 3 PEARLS/KEYNOTE-091 study.
Document Type
Article
Author
Oselin, Kersti; Shim, Byoung Yong; Okada, Morihito; Bryl, Maciej; Bonanno, Laura; Demirag, Guzin; Colantonio, Ida; Kimmich, Martin; Janzic, Urska; Vansteenkiste, Johan F.; Bernabe Caro, Reyes; Scherz, Amina; Curioni-Fontecedro, Alessandra; Früh, Martin; Wollner, Mira; Yang, Jing; Shariati, Nazly; Marreaud, Sandrine; Peters, Solange; O'Brien, Mary ER
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p8520-8520, 1p
Subject
Language
ISSN
0732183X